Raleigh Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $58.3K | Sell |
131
-342
| -72% | -$152K | 0.02% | 261 |
|
|
2025
Q1 | $229K | Buy |
473
+237
| +100% | +$115K | 0.1% | 184 |
|
|
2024
Q4 | $95K | Sell |
236
-13
| -5% | -$5.24K | 0.04% | 254 |
|
|
2024
Q3 | $116K | Buy |
249
+2
| +0.8% | +$930 | 0.04% | 251 |
|
|
2024
Q2 | $116K | Buy |
247
+35
| +17% | +$16.4K | 0.05% | 235 |
|
|
2024
Q1 | $88.6K | Buy |
212
+162
| +324% | +$67.7K | 0.04% | 246 |
|
|
2023
Q4 | $20.4K | Buy |
50
+30
| +150% | +$12.2K | 0.01% | 436 |
|
|
2023
Q3 | $7.01K | Buy |
20
+1
| +5% | +$350 | ﹤0.01% | 620 |
|
|
2023
Q2 | $6.69K | Hold |
19
| – | – | ﹤0.01% | 573 |
|
|
2023
Q1 | $5.99K | Buy |
+19
| New | +$5.99K | ﹤0.01% | 586 |
|
|
2022
Q1 | – | Sell |
-4
| Closed | -$1K | – | 691 |
|
|
2021
Q4 | $1K | Buy |
+4
| New | +$1K | ﹤0.01% | 299 |
|